Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on June 1, 2026

an hour ago

SAIC Announces First Quarter of Fiscal Year 2027 Results

Indeterminate GlobeNewswire

an hour ago

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Indeterminate GlobeNewswire

an hour ago

Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers

Indeterminate GlobeNewswire

an hour ago

Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

an hour ago

Lantronix Launches SLC 9000 to Secure AI Data Centers and Mission-Critical Networks at Scale

Indeterminate GlobeNewswire

an hour ago

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026

Indeterminate GlobeNewswire

an hour ago

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire

an hour ago

Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026

Indeterminate GlobeNewswire

an hour ago

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

Indeterminate GlobeNewswire

an hour ago

Waldencast Announces Sale of Obagi Medical to Bridgepoint

Indeterminate GlobeNewswire

2 hours ago

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire

2 hours ago

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Indeterminate GlobeNewswire

2 hours ago

Soualiga Holdings Acquires My Personal Recruiter, Appoints Kareem Miller as CEO

Indeterminate GlobeNewswire

2 hours ago

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Indeterminate GlobeNewswire

2 hours ago

ASUS Republic of Gamers Unveils ROG G1000 Edition 20 Desktop and ROG Xbox Ally X20 Bundle at Computex 2026

Indeterminate GlobeNewswire

3 hours ago

Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases

Indeterminate GlobeNewswire

3 hours ago

ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026

Indeterminate GlobeNewswire

3 hours ago

PageUp Expands Partner Ecosystem with Flockity, Vouch, and Certn to Drive Authentic, Integrated Hiring

Indeterminate GlobeNewswire

3 hours ago

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

Indeterminate GlobeNewswire